|
| (i) “luxury” oxygenation with inspiratory FiO2 0,6–1,0 | |
| (ii) Moderate hyperventilation (goal: PaCO2 30–35 mmHg) | |
| (iii) Avoidance of metabolic acidosis (pH > 7,4) | |
| (iv) Recruitment maneuver to avoid ventilation/perfusion mismatch | |
| (v) Low-tidal-volume ventilation to avoid overinflation of aveoli (goal: 6–8 mL/kg ideal body weight) | |
| (vii) Temperature management to maintain body temperature of 36-37°C | |
| (viii) “goal-directed” fluid and volume therapy with hemodynamic monitoring | |
|